Akin Demet, Manier D Hal, Sanders-Bush Elaine, Shelton Richard C
Department of Psychiatry, Vanderbilt University School of Medicine, Nashville, TN 37212, USA.
Int J Neuropsychopharmacol. 2005 Mar;8(1):5-16. doi: 10.1017/S146114570400478X. Epub 2004 Oct 22.
Intracellular signal transduction cascades, particularly those linked to protein kinases A (PKA) and C (PKC), have been implicated in mood disorders. This study examined the activity of PKA and PKC, as well as levels of PKA regulatory (R) and catalytic (C) subunit proteins, in fibroblasts cultured from skin biopsies from patients with major depression, melancholic subtype, in contrast to non-melancholic depressives and controls (n = 12 each group). PKA activity was determined as a function of the transfer of 32P to a target polypeptide, Kemptide. R and C subunit expression was assayed in the melancholic depressed and normal control groups by Western blots. In a separate experiment, the degree of phosphorylation of the endogenous substrate cAMP response element-binding protein (CREB) was estimated in samples from melancholic and non-melancholic patients and normal controls (n = 8 each) after incubation with isoproterenol or phorbol ester, which activate PKA and PKC respectively. Melancholics had significantly reduced phosphorylation of Kemptide in contrast to non-melancholics and controls. This was associated with lower levels of PKA RII alpha, C alpha, and C beta subunit isoform proteins, but not RI alpha, RI beta, or RII beta. Furthermore, activation of both PKA and PKC was associated with reduced CREB-P in melancholics relative to normal controls. Finally, PKA activity was found to correlate positively with Hamilton depression scores after 16 weeks of treatment with serotonin reuptake inhibitor antidepressants. These data further implicate signal transduction abnormalities in melancholic major depression, particularly PKA and PKC. This suggests an abnormality of factors controlling the expression or degradation of these enzymes.
细胞内信号转导级联反应,尤其是那些与蛋白激酶A(PKA)和蛋白激酶C(PKC)相关的反应,与情绪障碍有关。本研究检测了重度抑郁 melancholic 亚型患者皮肤活检培养的成纤维细胞中PKA和PKC的活性,以及PKA调节(R)亚基和催化(C)亚基蛋白的水平,并与非 melancholic 抑郁症患者和对照组(每组n = 12)进行对比。PKA活性通过32P向靶多肽Kemptide的转移来测定。通过蛋白质印迹法检测 melancholic 抑郁症组和正常对照组中R和C亚基的表达。在另一项实验中,在分别用异丙肾上腺素或佛波酯孵育后,估计 melancholic 和非 melancholic 患者及正常对照组(每组n = 8)样本中内源性底物环磷酸腺苷反应元件结合蛋白(CREB)的磷酸化程度,异丙肾上腺素和佛波酯分别激活PKA和PKC。与非 melancholic 患者和对照组相比,melancholic 患者Kemptide的磷酸化显著降低。这与较低水平的PKA RIIα、Cα和Cβ亚基同工型蛋白有关,但与RIα、RIβ或RIIβ无关。此外,相对于正常对照组,PKA和PKC的激活均与 melancholic 患者中CREB-P的降低有关。最后,在用5-羟色胺再摄取抑制剂抗抑郁药治疗16周后,发现PKA活性与汉密尔顿抑郁评分呈正相关。这些数据进一步表明 melancholic 重度抑郁症存在信号转导异常,尤其是PKA和PKC。这提示了控制这些酶表达或降解的因素存在异常。